Kosteneffectiviteit van statines

P.D. Gumbs; W.M.M. Verschuren; A.K. Mantel-Teeuwisse; A. De Boer; O.H. Klungel

Kosteneffectiviteit van statines

Translated title of the contribution: Drug treatment of hypercholesterolemia: Cost-effective treatment with statins for more patients

P.D. Gumbs, W.M.M. Verschuren, A.K. Mantel-Teeuwisse, A. De Boer, O.H. Klungel

Rijksinstituut voor Volksgezondheid en Milieu (RIVM)

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Drug treatment of hypercholesterolemia: Cost-effective treatment with statins for more patients
Original language	Dutch
Pages (from-to)	982-983
Number of pages	2
Journal	Pharmaceutisch Weekblad
Volume	140
Issue number	32
Publication status	Published - 12 Aug 2005

Keywords

hydroxymethylglutaryl coenzyme A reductase inhibitor
low density lipoprotein cholesterol
mevinolin
pravastatin
simvastatin
article
cardiovascular risk
cost effectiveness analysis
human
hypercholesterolemia
risk management

Cite this

@article{e405f9854bc548b8a796b4d491f5600c,

title = "Kosteneffectiviteit van statines",

keywords = "hydroxymethylglutaryl coenzyme A reductase inhibitor, low density lipoprotein cholesterol, mevinolin, pravastatin, simvastatin, article, cardiovascular risk, cost effectiveness analysis, human, hypercholesterolemia, risk management",

author = "P.D. Gumbs and W.M.M. Verschuren and A.K. Mantel-Teeuwisse and {De Boer}, A. and O.H. Klungel",

year = "2005",

month = aug,

day = "12",

language = "Dutch",

volume = "140",

pages = "982--983",

journal = "Pharmaceutisch Weekblad",

issn = "0031-6911",

publisher = "Kon. Ned. Mij. ter Bevordering der Pharmacie (KNMP)",

number = "32",

}

TY - JOUR

T1 - Kosteneffectiviteit van statines

AU - Gumbs, P.D.

AU - Verschuren, W.M.M.

AU - Mantel-Teeuwisse, A.K.

AU - De Boer, A.

AU - Klungel, O.H.

PY - 2005/8/12

Y1 - 2005/8/12

KW - hydroxymethylglutaryl coenzyme A reductase inhibitor

KW - low density lipoprotein cholesterol

KW - mevinolin

KW - pravastatin

KW - simvastatin

KW - article

KW - cardiovascular risk

KW - cost effectiveness analysis

KW - human

KW - hypercholesterolemia

KW - risk management

M3 - Article

SN - 0031-6911

VL - 140

SP - 982

EP - 983

JO - Pharmaceutisch Weekblad

JF - Pharmaceutisch Weekblad

IS - 32

ER -